Table of Contents
What changed
Revenue edged up 2.0% to NZ$87.2m and underlying EBITDA rose 6.4% to NZ$28.1m, with operating profit up 19.9% to NZ$22.9m and PBT up 15.2% to NZ$22.4m. NPAT, however, fell 15.4% to NZ$16.0m because the effective tax rate normalised from 2.7% to 28.5% — a 30.6pp gap between PBT growth and NPAT growth that is entirely tax-driven, not operational.
Cash told a very different story. Operating cash flow collapsed from NZ$4.5m to NZ$0.0m while capex more than doubled to NZ$9.4m (10.8% of revenue versus 4.7% a year ago), producing pre-lease free cash flow of roughly −NZ$9.4m. The swing was absorbed by a NZ$28.5m inventory build, with inventories up 65.4% to NZ$72.0m and implied inventory days stretching to ~301 from ~189.
Despite that, the balance sheet optically strengthened: cash rose to NZ$25.7m, gross borrowings fell to NZ$7.3m from NZ$16.3m, and the group moved to a net cash position of ~NZ$18.4m (vs ~NZ$3.6m). Revenue concentration remains NZ-heavy at ~71%, with France/India at ~23.5% and France HiRel at ~10.7%.
What matters
- Earnings quality read is PBT, not NPAT. The headline NPAT decline is a tax artefact; PBT up 15.2% on 2% revenue growth is the cleaner operating signal. Gross margin did compress ~97bps to 49.9%, so the EBITDA gain came more from operating leverage/cost control than from pricing.
- Cash conversion has broken. OCF/EBITDA went from 17.1% to 0.1%. That is not a rounding issue — it is a working-capital event, and the inventory line identifies where the cash went. Whether this is pre-positioning for second-half demand or stranded stock is the single most important question in this result.
- Balance sheet direction is ambiguous. Net debt improved sharply, but the improvement pre-dates the current period's cash burn; the NZ$18.4m net cash position coexists with materially heavier capex (~NZ$9.4m) and a large inventory carry. If the inventory does not unwind, the net cash buffer will thin quickly.
Expectations
No forward guidance, order book, or quantitative target was disclosed in the extracted release. On shape, HY22 was 49.7% of FY22 revenue but 57.2% of FY22 NPAT, so the prior year was modestly second-half weighted on revenue but first-half weighted on profit. Annualising HY23 revenue gives ~NZ$174.3m, only marginally above FY22's NZ$172.0m — so the release does not support a step-change in the top-line trajectory. It does support a stable-to-slightly-improving underlying earnings base on a pre-tax view, but it does not support confidence in cash delivery without a second-half inventory unwind.
Quality of result
Mixed. The pre-tax earnings improvement appears durable in the sense that it is driven by operating profit up NZ$3.8m on near-flat gross profit (NZ$43.5m vs NZ$43.5m) — i.e. cost discipline below the gross line rather than a margin expansion story. EBITDA growth of 6.4% on 2% revenue growth is consistent with that read.
However, the result is heavily balance-sheet-assisted in cash terms. Without the inventory build, operations would have thrown off materially more cash; with it, the business is funding growth through working capital and capex and producing negative free cash flow. ROE weakened to 11.5% from 15.7%, consistent with an enlarged asset base (total assets up 23.1% to NZ$218.4m) not yet translating into proportional earnings. Underlying EBITDA is also a non-GAAP measure with no reconciliation table in the extract, which limits how cleanly it can be relied on in isolation.
Unresolved
- Is the NZ$28.5m inventory build demand-led pre-positioning, a supply-chain buffer, or slow-moving stock that will need to be written down?
- What drove the 97bps gross margin compression — input costs, product mix, or pricing?
- Why did capex step up to 10.8% of revenue, and is this a new run-rate tied to the India facility or a one-off?
- What is the dividend position for the period? The extraction flags an "Interim/Final Dividend" line but no amount is captured.
- How much of the NZ$6.3m FX uplift to cash flatters the reported cash position, given disclosed multi-currency operations?
This briefing cannot assess customer concentration, forward order book, or segment profitability, as none of these were disclosed in the supplied excerpts.
Key metrics
| Metric | HY23 | HY22 | Change |
|---|---|---|---|
| Revenue | $87.2m | $85.4m | +2.0% ↑ |
| EBITDA | $28.1m | $26.4m | +6.4% ↑ |
| Net profit after tax | $16.0m | $18.9m | -15.4% ↓ |
| Net cash inflow from operating activities | $0.0m | $4.5m | -99.6% ↓ |
| Operating profit | $22.9m | $19.1m | +19.9% ↑ |
| Profit before tax | $22.4m | $19.5m | +15.2% ↑ |
| Cash and cash equivalents | $25.7m | $19.9m | +29.2% ↑ |
| Total assets | $218.4m | $177.4m | +23.1% ↑ |
Reference: annolyse.ai/briefings/rak-hy23
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| NZ | $61.9m | — | — | n/a |
| France/India | $20.5m | — | — | n/a |
| France HiRel | $9.4m | — | — | n/a |
| Other | −$4.6m | — | — | n/a |
Reference: annolyse.ai/briefings/rak-hy23
Analytical metrics
| Metric | HY23 | HY22 | Context |
|---|---|---|---|
| PBT growth | +15.2% | — | cleaner earnings measure |
| Effective tax rate | 28.5% | 2.7% | — |
| OCF / EBITDA (cash conversion) | 0.1% | 17.1% | deteriorated |
| FCF pre-lease | −$9.4m | $0.5m | −$9.9m |
| FCF post-lease | −$9.4m | $0.5m | −$9.9m |
| FCF / NPAT | -58.7% | 2.6% | complementary conversion metric |
| Capex % revenue | 10.8% | 4.7% | — |
| Capex | $9.4m | $4.0m | +$5.4m |
| Inventory days | 300.6 | 189.1 | +111.5 days |
| Net debt | −$18.4m | −$3.6m | −$14.8m |
| Net debt / EBITDA | -0.66x | -0.14x | Strengthening |
| Gross borrowings | $7.3m | $16.3m | −$9.0m |
| ROE (annualised) | 11.5% | 15.7% | Weakening |
| HY22 share of FY22 revenue | 49.7% | — | Other half was 50.3% |
| HY22 share of FY22 NPAT | 57.2% | — | Other half was 42.8% |
| Profit from continuing operations | $16.0m | $18.9m | −$2.9m |
Reference: annolyse.ai/briefings/rak-hy23
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.